A detailed history of Janney Montgomery Scott LLC transactions in Pfizer Inc stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 2,820,677 shares of PFE stock, worth $77.5 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
2,820,677
Previous 2,677,330 5.35%
Holding current value
$77.5 Million
Previous $74.9 Million 8.97%
% of portfolio
0.23%
Previous 0.23%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$27.7 - $31.39 $3.97 Million - $4.5 Million
143,347 Added 5.35%
2,820,677 $81.6 Million
Q2 2024

Jul 25, 2024

BUY
$25.26 - $29.6 $4.12 Million - $4.83 Million
163,017 Added 6.48%
2,677,330 $74.9 Million
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $745,554 - $856,134
28,797 Added 1.16%
2,514,313 $69.8 Million
Q4 2023

Feb 07, 2024

SELL
$26.13 - $33.94 $3.35 Million - $4.35 Million
-128,149 Reduced 4.9%
2,485,516 $71.6 Million
Q3 2023

Nov 08, 2023

SELL
$32.09 - $37.51 $3.1 Million - $3.63 Million
-96,723 Reduced 3.57%
2,613,665 $86.7 Million
Q2 2023

Jul 26, 2023

BUY
$36.12 - $41.79 $1.73 Million - $2 Million
47,807 Added 1.8%
2,710,388 $99.4 Million
Q1 2023

Apr 28, 2023

SELL
$39.39 - $51.28 $569,776 - $741,765
-14,465 Reduced 0.54%
2,662,581 $109 Million
Q4 2022

Feb 01, 2023

BUY
$41.75 - $54.5 $3.67 Million - $4.79 Million
87,860 Added 3.39%
2,677,046 $137 Million
Q3 2022

Oct 25, 2022

BUY
$43.76 - $53.42 $3.47 Million - $4.24 Million
79,364 Added 3.16%
2,589,186 $113 Million
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $2.42 Million - $2.86 Million
51,923 Added 2.11%
2,509,822 $128 Million
Q1 2022

May 04, 2022

BUY
$45.75 - $56.69 $2.5 Million - $3.1 Million
54,633 Added 2.27%
2,457,899 $127 Million
Q4 2021

Jan 27, 2022

BUY
$41.32 - $61.25 $2 Million - $2.97 Million
48,473 Added 2.06%
2,403,266 $142 Million
Q3 2021

Oct 29, 2021

BUY
$39.25 - $50.42 $62,486 - $80,268
1,592 Added 0.07%
2,354,793 $101 Million
Q2 2021

Jul 26, 2021

SELL
$35.91 - $40.68 $2.39 Million - $2.7 Million
-66,485 Reduced 2.75%
2,353,201 $92.2 Million
Q1 2021

Apr 27, 2021

BUY
$33.49 - $37.77 $792,674 - $893,978
23,669 Added 0.99%
2,419,686 $87.7 Million
Q4 2020

Jan 25, 2021

BUY
$33.47 - $42.56 $5.26 Million - $6.69 Million
157,130 Added 7.02%
2,396,017 $88.2 Million
Q3 2020

Nov 06, 2020

BUY
$31.75 - $37.25 $347,027 - $407,142
10,930 Added 0.49%
2,238,887 $82.2 Million
Q2 2020

Jul 23, 2020

SELL
$30.12 - $36.54 $4.85 Million - $5.88 Million
-161,042 Reduced 6.74%
2,227,957 $72.9 Million
Q1 2020

Apr 30, 2020

BUY
$27.03 - $38.62 $4.8 Million - $6.85 Million
177,470 Added 8.02%
2,388,999 $78 Million
Q4 2019

Jan 21, 2020

BUY
$32.92 - $37.36 $3.8 Million - $4.31 Million
115,424 Added 5.51%
2,211,529 $86.6 Million
Q3 2019

Oct 29, 2019

BUY
$32.49 - $42.13 $2.28 Million - $2.95 Million
70,105 Added 3.46%
2,096,105 $75.3 Million
Q2 2019

Jul 29, 2019

BUY
$36.98 - $41.52 $3.56 Million - $4 Million
96,378 Added 4.99%
2,026,000 $87.8 Million
Q1 2019

Apr 30, 2019

BUY
$37.5 - $41.2 $1.27 Million - $1.39 Million
33,808 Added 1.78%
1,929,622 $82 Million
Q4 2018

Feb 01, 2019

SELL
$38.47 - $43.86 $4.61 Million - $5.25 Million
-119,740 Reduced 5.94%
1,895,814 $82.8 Million
Q3 2018

Nov 05, 2018

SELL
$34.47 - $41.81 $56,875 - $68,986
-1,650 Reduced 0.08%
2,015,554 $88.8 Million
Q2 2018

Jul 24, 2018

SELL
$32.98 - $35.16 $2.06 Million - $2.2 Million
-62,495 Reduced 3.01%
2,017,204 $73.2 Million
Q1 2018

Apr 19, 2018

BUY
$31.91 - $37.02 $5.03 Million - $5.83 Million
157,491 Added 8.19%
2,079,699 $73.8 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $2.47 Million - $2.62 Million
74,262 Added 4.02%
1,922,208 $69.6 Million
Q3 2017

Nov 15, 2017

BUY
$31.0 - $34.15 $57.3 Million - $63.1 Million
1,847,946
1,847,946 $66 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.